Plain-English peptide and
hormone education.
140 articles, reviewed by licensed physicians. Browse by topic or search across the catalog.
Learning paths
Browse by intent
5 protocolsBrowse by peptide
12 peptidesBrowse by topic
11 topics140 articles
The men's midlife biomarker panel: what to include in 2026
The men's midlife biomarker panel in plain English — what to include, why each marker matters, and how the 2026 list updates the standard physical.
Read article
The hallmarks of aging: how the field maps biological decline
The hallmarks of aging in plain English — the 12 biological processes longevity researchers track, and why this framework guides modern preventive medicine.
Thymosin alpha-1: what this immune peptide is
Thymosin alpha-1 in plain English — what it is, where it comes from in the body, and why clinicians are paying attention to this immune-modulating peptide.
GLP-1 research: SELECT trial and the published evidence base
GLP-1 research base in plain English — the SELECT trial cardiovascular results, what STEP and SUSTAIN added, and how the evidence evolved between 2016 and 2026.
Perimenopause symptoms: which are common and which need attention
Perimenopause symptoms in plain English — what is normal, what is common, and which symptoms deserve a clinician call. The full midlife symptom map.
Perimenopause vs menopause: how the two stages differ
Perimenopause vs menopause in plain English — what changes, when it starts, why the experience differs, and what each stage actually means medically.
CJC-1295 side effects: what the literature reports
CJC-1295 side effects in plain English — what the published literature reports, common reactions, and what should prompt a clinician call promptly.
Sermorelin FAQ: the top questions answered
Sermorelin FAQ — what it is, how it works, who it is for, side effects, and regulatory status. Plain-English answers to the most common sermorelin questions.
Testosterone panels for men: what total, free, and SHBG mean together
A testosterone panel is three numbers, not one. Plain-English breakdown of total testosterone, free testosterone, and SHBG — and why all three matter together.
NAD+ and peptides: how they work in complementary lanes
NAD+ supports cellular energy. Peptides act through specific receptors. They are not competitors — they live in different lanes of the longevity conversation.
Ozempic face: what it is and what to do about it
Ozempic face is a colloquial term for the gaunt look some people get after rapid weight loss on GLP-1 therapy. Plain-English biology and what the research suggests.
Estrogen decline and skin aging: where peptides fit in
Estrogen decline thins skin, slows collagen, and shifts how skin holds water. A plain-English look at the biology — and where copper peptides like GHK-Cu fit in.
Peptide stack for menopause: addressing the five most common symptoms
Menopause shifts five things at once: sleep, skin, mood, body composition, and libido. A plain-English guide to which peptides have research behind them — and which do not.
TRT vs peptide secretagogues: two different philosophies
TRT replaces a hormone. Peptide secretagogues nudge the body to make more of its own. A plain-English breakdown of the two philosophies and when each makes sense.
CJC-1295 with DAC vs without DAC: which form and why
CJC-1295 comes in two forms — with DAC and without. Plain-English breakdown of how each one signals growth hormone, and why clinicians pick one over the other.
GLP-1 and sleep apnea: what the FDA indication actually means
What the FDA tirzepatide-for-sleep-apnea indication means: who it covers, what the SURMOUNT-OSA trial showed, and where compounded preparations stand today.
HOMA-IR: the simple calculation that maps insulin resistance
HOMA-IR in plain English: a simple formula using fasting glucose and fasting insulin that estimates insulin resistance. How to calculate it and how to read it.
Low libido in men: what to investigate before reaching for a pill
Low libido in men is rarely just a libido problem. The plain-English checklist a clinician runs through before testosterone, peptides, or anything else.
CJC-1295 and ipamorelin for women: sleep, skin, and recovery
CJC-1295 plus ipamorelin in midlife women, in plain English: how it is studied for sleep, skin, and recovery, and what the literature does and does not show.
Peptides and collagen: beyond the topical creams
Why injectable peptides like GHK-Cu signal collagen differently than topical creams or oral collagen powders. What the dermatology literature actually shows.
How tesamorelin targets visceral fat: the mechanism
How tesamorelin works, in plain English: a stabilized GHRH analog that signals the pituitary for more growth hormone, with a measured effect on visceral fat.
MK-677 side effects: water retention, insulin, appetite, and more
MK-677 side effects in plain English: water retention, blood-sugar shifts, appetite changes, and what the published clinical trials describe. Not FDA-approved.
Off-label prescribing explained: what it means and why it is common
What off-label prescribing is in plain English: it is legal, it is common, and most physicians do it every week. Why peptide protocols often live in this space.
What happens at a peptide telehealth consultation
A plain-English walkthrough of a peptide telehealth visit: what the clinician asks, what labs you may need, and how a prescription gets compounded and shipped.
Receptor specificity: why peptides are more targeted than small-molecule drugs
Peptides are more receptor-specific than most small-molecule drugs. Here is what that means in plain English — and why specificity is not risk-free.
Sterility testing in compounded peptides: what the standards require
Compounded injectable peptides must meet USP <797> sterility standards. Here is what the standards require — and what to look for in a 503A pharmacy.
Fasting insulin: the metabolic marker your standard panel might miss
Fasting glucose can look fine while fasting insulin is climbing for years. Here is why this lab matters — and why it is rarely on a standard panel.
Thymosin alpha-1 dosing: what published protocols describe
Published thymosin alpha-1 dosing comes from international Zadaxin trials. Here is what the trial protocols describe — and why dosing is a clinician decision.
PT-141 side effects: what the literature reports and how nausea is managed
Vyleesi (bremelanotide / PT-141) is FDA-approved for one use; the compounded version is not FDA-approved. Here is what the side effect literature shows.
How compounded tirzepatide works: the dual GIP/GLP-1 mechanism
Tirzepatide is a dual incretin agonist that signals two appetite pathways at once. Here is the mechanism in plain English — and what compounded means.
GHK-Cu vs hyaluronic acid: two different jobs in the skin
GHK-Cu and hyaluronic acid are often pitched as rivals, but they do completely different jobs. Here is a clear comparison of mechanism, evidence, and use.
Ipamorelin side effects: what the literature reports
Ipamorelin is among the cleanest GHRPs in the literature, but it is not side-effect free. Here is what the published trials and case reports actually describe.
How CJC-1295 extends GHRH signaling: the mechanism
CJC-1295 is a modified GHRH analog with extended half-life. Here is how the mechanism works in plain English — and what makes it different from sermorelin.
Thymosin alpha-1 side effects and contraindications
Thymosin alpha-1 side effects in trials are usually mild — injection-site soreness, mild flu-like feeling, occasional rash. Plus the contraindications.
Compounded tirzepatide: what this dual agonist actually is
Compounded tirzepatide is a dual GLP-1/GIP agonist prepared by 503A pharmacies. The compounded version is not FDA-approved. Here is what the molecule is.
GHK-Cu side effects and what to know before using it
GHK-Cu side effects in dermatology trials are usually mild: brief redness, mild itch, occasional metallic taste with injectable forms. Here is what to flag.
Sermorelin side effects: what the literature reports
Sermorelin side effects in trials are usually mild and short-lived: injection-site reactions, brief flushing, occasional headache. Here is what to flag.
How subcutaneous peptide injections work: a plain-English primer
A subcutaneous peptide injection sits just under the skin in fatty tissue. Here is what that means in plain English and why peptides need an injection.
Thymosin alpha-1 research: where it has been studied
Thymosin alpha-1 has decades of clinical research behind it, mostly in infectious disease and immune contexts. Here is what the thymosin alpha-1 research base actually shows.
PT-141 research: bremelanotide in the published literature
PT-141 (bremelanotide) is a melanocortin receptor agonist with FDA approval for one specific indication in women. Here is what the PT-141 research literature actually shows.
How semaglutide activates GLP-1 receptors: the mechanism
Semaglutide is a long-acting GLP-1 receptor agonist. It works through three pathways: appetite, gastric emptying, and insulin. Here is the plain-English semaglutide mechanism.
GHK-Cu vs retinol: how copper peptides and vitamin A compare
GHK-Cu and retinol both have skin research behind them, but they work through different pathways. Here is the plain-English GHK-Cu vs retinol comparison, with what the evidence supports.
GHK-Cu research: what the published dermatology literature shows
GHK-Cu has decades of dermatology research behind it, mostly in cell and small-scale skin studies. Here is what the GHK-Cu research base actually shows, in plain English.
Tesamorelin: the FDA-approved GHRH analog explained
Tesamorelin (Egrifta) is FDA-approved for one HIV-related indication while the compounded version is not FDA-approved. Here is the plain-English primer on this GHRH analog.
Ipamorelin research: published evidence reviewed
Ipamorelin is a selective growth hormone secretagogue with a well-described animal record and a smaller human one. Here is what the ipamorelin research base actually shows.
IGF-1 lab reference ranges: what an optimal level looks like by age
IGF-1 reference ranges in plain English: how a routine lab is reported, what an optimal level looks like across age, and where the conversation gets nuanced.
PT-141 vs sildenafil: two different mechanisms for two different problems
PT-141 vs sildenafil in plain English: a brain peptide that signals desire vs a vascular drug that supports erection. Two mechanisms, two different problems, side by side.
Sermorelin for women: growth hormone decline and what it looks like
Sermorelin for women in plain English: how growth hormone changes through midlife, what a GHRH analog does, and what the published literature actually supports.
GHK-Cu and wound healing: the regenerative mechanism explained
GHK-Cu wound healing in plain English: how a tiny copper-binding peptide signals tissue repair, what the research describes, and where the evidence stops.
Peptides and male fertility: what the literature actually links
Peptides and male fertility in plain English: what the published literature actually links between metabolic health, growth hormone peptides, and sperm parameters.
GLP-1 and testosterone: the metabolic connection in men
GLP-1 therapy and testosterone in men: a plain-English read on the metabolic link, what the research describes, and why weight loss often shifts hormone numbers.
Retatrutide 2026: what the triple-agonist trial results actually showed
Retatrutide phase-3 trial results in plain English: what a triple agonist of GLP-1, GIP, and glucagon receptors actually achieved, and what the data does not tell you yet.
FDA's March 2026 wave: 30 telehealth warning letters explained
FDA sent ~30 warning letters to telehealth companies in March 2026 over compounded GLP-1 marketing and prescribing. What was flagged, and what it means for patient access.
Skin peptides 101: a primer for women who want the science
Skin peptides 101 in plain English: GHK-Cu and a few research-backed signaling peptides that may support collagen and skin barrier. The honest version, not the marketing one.
The growth hormone axis explained: pituitary, GHRH, and IGF-1
The growth hormone axis explained in plain English: hypothalamus releases GHRH, pituitary releases GH, liver makes IGF-1. The dispatcher–driver–receipt model patients can actually use.
Why most peptides cannot be taken as pills: bioavailability basics
Why most peptides cannot be taken as pills: stomach acid breaks them down and the gut wall blocks absorption. Plain-English bioavailability basics for patients.
The baseline blood panel: what to test before any peptide protocol
The baseline blood panel before peptide therapy in plain English: CMP, lipid panel, A1C, fasting insulin, IGF-1, testosterone, hs-CRP. Why a starting number is the only way to measure change.
Peptides for men in midlife: a framework for starting smart
Peptides for men in midlife: a plain-English framework. Start with goals, run a baseline blood panel, pick one well-studied peptide, and measure. Why fewer changes beat more changes.
How thymosin alpha-1 signals the immune system: the mechanism
Thymosin alpha-1 mechanism in plain English: a 28-amino-acid peptide from the thymus that activates toll-like receptors to nudge T cells and dendritic cells toward action.
503A pharmacy quality standards: what to look for
503A pharmacy quality standards in plain English: USP-797 sterility, PCAB accreditation, certificate of analysis, and licensed-state pharmacist oversight. What to ask before you fill.
Bremelanotide is FDA-approved for women: what Vyleesi actually treats
Bremelanotide (Vyleesi) is FDA-approved for premenopausal women with HSDD. The branded form is FDA-approved; compounded PT-141 is not. What the label actually covers, in plain English.
Tirzepatide: what this dual GIP/GLP-1 agonist actually is
Tirzepatide explained in plain English: a once-weekly injection that copies two gut hormones at once. Branded Mounjaro and Zepbound are FDA-approved; compounded versions are not.
GLP-1: what this gut hormone actually is
GLP-1 is a gut hormone the body releases after eating. It signals fullness, slows stomach emptying, and helps insulin work. Here is what it is, in plain English.
Sarcopenia explained: the muscle loss most people miss
Sarcopenia is the gradual age-related loss of muscle mass, strength, and function. Here is what it is — and why catching it early matters in plain English.
Healthspan vs lifespan: what the longevity field actually studies
Lifespan is how long you live. Healthspan is how long you live well. Here is what the longevity field is actually studying — and why the distinction matters.
Collagen and the skin: what the peptide literature actually shows
Collagen is the protein that gives skin its shape. Here is what published research actually says about peptides and collagen — and what is still being studied.
Perimenopause explained: what is happening and when
Perimenopause is the years-long transition before menopause when ovarian hormones swing and shift. Here is what is happening — and why the timing varies so much.
How MK-677 stimulates growth hormone: the ghrelin pathway
MK-677 mechanism explained: ibutamoren mimics the body's hunger hormone ghrelin to push the pituitary into releasing growth hormone. Here is how.
Ipamorelin: what this GHRP peptide is
Ipamorelin is a five-amino-acid synthetic peptide in the GHRP family that signals the pituitary to release growth hormone. Here is what it is, in plain English.
What is a peptide: a plain-English primer
A peptide is a short chain of amino acids — bigger than a single amino acid, smaller than a protein. Here is what that means, in plain English.
What happens to cardiovascular risk when you stop GLP-1 therapy
What happens to cardiovascular risk when GLP-1 therapy stops in plain English: weight, blood pressure, and metabolic markers tend to drift back, and the heart-risk reduction can fade with them.
The original GHK-Cu research: what Pickart actually found
The original GHK-Cu research from Dr. Loren Pickart in plain English: a tiny peptide isolated from blood plasma in the 1970s with decades of skin and tissue repair studies.
Why GHK-Cu searches surged in 2026
GHK-Cu searches surged in 2026 in plain English: regulatory news, social posts, and a real research base around skin and hair drove the renewed attention.
Sermorelin and sleep: what the data shows
Sermorelin and sleep in plain English: a GHRH analog dosed at night may support deeper sleep, but the published data is mixed and individual response varies.
Growth hormone peptides and sleep architecture: the research
Growth hormone peptides and sleep in plain English: most natural GH release happens in deep sleep, and peptide therapies aim to support that same window.
How peptides are made: from amino acid to injectable
How peptides are made in plain English: amino acids are linked one at a time on a solid bead, purified, tested, and shipped to a compounding pharmacy.
Endogenous vs exogenous peptides: natural vs synthetic
Endogenous vs exogenous peptides explained in plain English: your body makes some, a lab makes others, and many therapies copy the natural version on purpose.
How peptides are different from supplements
Peptides vs supplements in plain English: peptides are prescribed compounds prepared by a pharmacy. Supplements are not. Here is the clean way to tell them apart.
What happens inside a compounding pharmacy
A walkthrough of what actually happens inside a 503A compounding pharmacy — from the active pharmaceutical ingredient to the labeled vial — in plain English.
What are biomarkers, and why do they matter for peptide protocols?
A biomarker is anything measurable that tells you how a system is functioning. Here is what they mean for peptide protocols, and the labs most clinicians check before starting.
PT-141 for women: the brain-based path to desire
PT-141 (bremelanotide) acts in the brain — not in the bloodstream — and the FDA-approved version is indicated for premenopausal HSDD. Here is the plain-English breakdown.
Retatrutide vs tirzepatide vs semaglutide: a plain-English comparison
Retatrutide, tirzepatide, semaglutide compared in plain English: how many receptors each one hits, what the trials showed, and where each currently stands with the FDA.
GHK-Cu for hair: what the collagen-stimulating research shows
GHK-Cu and hair: copper peptides have decades of research on follicle biology and collagen. Here is what the studies actually show — and what they don't.
Peptide therapy for women in perimenopause: what changes in your 40s
Perimenopause shifts hormones, sleep, and skin in ways that peptide therapy is being studied to address. Here is a plain-English starter framework — and what to ask a clinician.
Sermorelin vs HGH: a GHRH analog vs the hormone itself
Sermorelin vs HGH in plain English: one prompts your pituitary to release its own growth hormone; the other pours it in from outside. Here is why that matters.
Ipamorelin: the selective GH secretagogue with the cleanest profile
Ipamorelin in plain English: a short peptide that nudges the pituitary to release growth hormone without spiking cortisol or hunger. Here is what the research actually shows.
How peptides are different from hormones
Peptides vs hormones in plain English: most hormones are peptides, but the labels describe different things. Here is the clean way to tell them apart.
Erectile dysfunction as a vascular-health signal
ED frequently precedes cardiovascular events by two to five years. Endothelial dysfunction is the shared mechanism. Here's what the published research says about ED as a screening opportunity.
Peptides 101: 10 questions first-time patients ask
Ten plain-English answers to the most common questions first-time patients ask about peptide therapy — what they are, how they work, and what to ask a clinician.
Needle gauge and length for peptide injections: a reference guide
Which needle do you use for a peptide injection? A plain-English reference to needle gauge and length for subcutaneous peptide administration.
Oxytocin beyond the stereotype: a peptide primer
Oxytocin is more than the 'love hormone' label suggests. Here's the neuroscience — pituitary origin, social bonding studies, and what the intranasal research actually shows.
How compounded peptides are made: API to vial
How does a compounding pharmacy actually make a peptide vial? A plain-English walk through API sourcing, sterile compounding, fill-finish, and quality testing.
How PT-141 signals desire through melanocortin receptors
How does PT-141 work? Unlike PDE5 inhibitors, bremelanotide acts in the brain, not the bloodstream. A plain-English walk through melanocortin receptor signaling.
Compounded semaglutide: what it is and how it differs from branded
Compounded semaglutide and branded semaglutide share the same active ingredient. Here is what compounded means, what is different, and what current law allows.
IGF-1 LR3: what the research actually shows
IGF-1 LR3 is a modified analog of IGF-1 with a longer half-life. Animal model data exists, but human safety evidence is limited. Here's an honest read of the literature.
What the July 2026 PCAC meeting could change
The FDA's Pharmacy Compounding Advisory Committee meets in July 2026 to review peptide reclassification. Here's what PCAC does, how it works, and what's on the agenda.
PT-141 (bremelanotide): how melanocortin signaling affects desire
PT-141 (bremelanotide) is the active ingredient in Vyleesi (FDA-approved for HSDD); compounded versions are not FDA-approved. How the melanocortin pathway works.
How GHK-Cu promotes collagen synthesis: the mechanism
GHK-Cu is a small copper-binding peptide that signals skin repair. Here is the mechanism in plain English: what it does to fibroblasts, collagen, and the dermal matrix.
The February 2026 HHS announcement on peptide reclassification
In February 2026, HHS proposed returning seven Category 2 peptides to Category 1 status. Here's what 'proposed' actually means procedurally — and what hasn't changed yet.
Dermastamp and microneedle basics
What microneedling does to skin at a biological level, the difference between clinical and at-home devices, and what the dermatology literature says about peptide delivery.
DEXA body composition scans and peptide protocols
DEXA scans measure lean mass, fat mass, and bone density with more precision than scale weight alone. Here's how they're used as a baseline for peptide protocols.
Novo Nordisk v. Hims and Hers: the compounded GLP-1 case
Novo Nordisk filed suit against Hims & Hers in February 2026 over compounded GLP-1 marketing. Here's the legal question at the center of the case.
Tesamorelin and visceral fat research
Tesamorelin (Egrifta) is FDA-approved for HIV-associated lipodystrophy. Here's what published trials show about its effects on visceral adipose tissue.
A1C and fasting glucose: the two metabolic baselines
A1C and fasting glucose measure different things about blood sugar. Here's how they work, what the ADA thresholds mean, and why both are relevant before a GLP-1 protocol.
FDA's February 2026 warning letter wave: what happened
In February 2026, the FDA issued roughly 30 warning letters to telehealth and compounding operators. Here's what the enforcement wave covered and why it matters.
Category 1 vs Category 2 peptides: the access framework
The FDA's Category 1 and Category 2 framework determines which peptides compounding pharmacies can legally prepare. Here's how it works.
CJC-1295: what this modified GHRH peptide is
CJC-1295 is a modified GHRH peptide. Here is what it is in plain English: what the molecule looks like, why DAC matters, and how it differs from sermorelin.
Collagen synthesis: what the peptide literature actually shows
What peer-reviewed research says about peptides and collagen synthesis — type I and III collagen, ECM remodeling, MMP regulation, and where the data has limits.
IGF-1 lab test: what the number means
IGF-1 is the primary marker clinicians use to assess GH-axis activity. Here's what the number measures, how reference ranges are age-adjusted, and what elevations mean.
Testosterone vs peptide secretagogues: how they differ
TRT replaces testosterone directly. GH secretagogues like sermorelin work upstream. They have different mechanisms, endpoints, and trade-offs.
Biomarkers commonly tracked during peptide protocols
A practical overview of the lab panels clinicians commonly order before and during peptide protocols — including IGF-1, A1C, CMP, lipids, and hormone markers.
Retatrutide: what the triple-agonist literature shows
Retatrutide is an investigational triple agonist targeting GLP-1, GIP, and glucagon receptors. Here's what the Phase 2 data published in NEJM 2023 shows.
How sermorelin signals growth hormone release
How does sermorelin actually trigger growth hormone? A plain-English walk through the GHRH receptor, the pituitary, and the pulse the body still controls.
GHK-Cu topical vs injection: different delivery, different data
Topical GHK-Cu serums and injectable GHK-Cu follow very different pharmacokinetics. Here's what the dermal penetration literature actually shows.
GLP-1 side effects in the published literature
Nausea, vomiting, constipation, and rarer events like pancreatitis are documented in GLP-1 trial literature. Here's what the published data shows.
Minimizing injection pain: what the research supports
Evidence from diabetes injection research points to several techniques associated with less injection discomfort. Here's what the literature actually supports.
Male fertility and insulin resistance: the literature link
Insulin resistance is associated with lower testosterone and changes in sperm parameters. Here's what the peer-reviewed literature says about the link.
GLP-1 rebound: why weight can return when therapy stops
STEP-4 trial data showed substantial weight return after stopping semaglutide. Understanding why requires a look at setpoint biology and appetite hormones.
Peptide storage and cold chain basics
Compounded peptides are temperature-sensitive. Here's how to store unopened and reconstituted vials correctly, and what to know about cold-chain shipping.
GHK-Cu: the copper peptide and skin biology
What GHK-Cu is, how it interacts with dermal biology, and what the published research actually says about this copper-binding tripeptide.
MK-677 (Ibutamoren): an oral growth-hormone secretagogue
MK-677 is an oral ghrelin-receptor agonist studied for raising IGF-1 in adults. Here's what the published research actually shows.
Muscle preservation during GLP-1 therapy
Lean mass loss is a documented concern during rapid weight reduction. Here's what the published literature says about preserving muscle on GLP-1 therapy.
How peptides are reconstituted: bacteriostatic water basics
Lyophilized peptides must be reconstituted before injection. Here's how bacteriostatic water works, why it differs from sterile water, and how to do it correctly.
Compounded GLP-1 microdosing: what the literature describes
Microdosing GLP-1 compounds means using sub-label doses. Here's what the published dose-response literature says — and what it doesn't.
Injection site rotation: why it matters
Rotating injection sites prevents lipohypertrophy and keeps absorption consistent. Here's a practical rotation pattern for abdominal and thigh sites.
GLP-1: what this gut hormone actually does
GLP-1 is a gut hormone that regulates insulin, slows digestion, and signals fullness to the brain. Here's what the published biology shows.
How subcutaneous peptide injections work
Subcutaneous peptide injections deliver compounds below the skin for stable, predictable absorption. Here's how the mechanism works and what to expect.
Why we're building Halftime Health
Why we're building a peptide telehealth company that tries to be more boring and more credible than most of what exists in this space right now.
CJC-1295 + Ipamorelin: why they are often combined
CJC-1295 and ipamorelin stimulate growth hormone through different receptors. Combined, they produce a synergistic GH pulse without raising cortisol or prolactin.
Thymosin alpha-1 and the immune system
Thymosin alpha-1 is a 28-amino-acid peptide derived from prothymosin-alpha that modulates T-cell maturation. Here's what the published research says.
Sermorelin explained: the GHRH analog
Sermorelin is a 29-amino-acid GHRH analog that stimulates the pituitary to release growth hormone. Here's how it works, what the research says, and what to know.
Single-vial peptide combinations: which ones work together
Not all peptides can be combined in one vial. Here's what determines compatibility — pH, diluent stability, dosing schedules — and which combinations are industry-established.
Gray-market research-use-only peptides: the real risk profile
RUO-labeled peptides are not intended for human use. No purity guarantees, no sterility testing, no dosing standards. Here's what the FDA and published literature say.
What PCAB accreditation means for compounding pharmacy quality
PCAB is a voluntary accreditation for compounding pharmacies covering sterility, quality, and USP 797/800 compliance. Here's what it means and why it matters.
503A vs 503B compounding pharmacies explained
503A pharmacies fill patient-specific prescriptions. 503B outsourcing facilities supply providers at scale. Here's what each means for your compounded peptide prescription.
Cycling peptides: what the research suggests about breaks
Why do peptide protocols include breaks? Receptor desensitization and tachyphylaxis are real biological phenomena. Here's what the research says about cycling.
Peptide half-life basics: why dosing schedules vary
Why do some peptides require daily injections while others work weekly? The answer is half-life. Here's a plain-English explanation of peptide pharmacokinetics.
How to have a goals-first conversation with your clinician
Before naming a compound, start with what you actually want. Here's how to structure a productive goals-first conversation with a clinician about peptide options.
Peptides vs small-molecule drugs: keys vs hammers
Peptides bind to specific receptors like a key in a lock. Small-molecule drugs work differently. Here's what that distinction means for how each interacts with your body.
What are peptides? A plain-English primer
Peptides are short chains of amino acids your body already makes. Learn what they are, how they differ from proteins, and why they matter for health research.